In response to the emergence of SARS-CoV-2 variants of concern, the global scientific
community, through unprecedented effort, has sequenced and shared over 11 million …

Monoclonal antibodies and antibody cocktails are a promising therapeutic and prophylaxis
for coronavirus disease 2019 (COVID-19). However, ongoing evolution of severe acute …

We compared 19,207 cases of SARS-CoV-2 variant B. 1.1. 7/S gene target failure (SGTF),
436 B. 1.351 and 352 P. 1 to non-variant cases reported by seven European countries …

The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.
1.1. 529 (Omicron) variant and its resistance to neutralization by vaccinee and convalescent …

INTRODUCTION Worldwide appearance of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variants of concern (VOCs) with increased transmissibility and resistance to …

Abstract Recently, the SARS-CoV-2 variants from the United Kingdom (UK), South Africa,
and Brazil have received much attention for their increased infectivity, potentially high …

The independent emergence late in 2020 of the B. 1.1. 7, B. 1.351, and P. 1 lineages of
SARS-CoV-2 prompted renewed concerns about the evolutionary capacity of this virus to …

SARS-CoV-2 spillback from humans into domestic and wild animals has been well
documented, and an accumulating number of studies illustrate that human-to-animal …

COVID-19 is a major health threat across the globe, which causes severe acute respiratory
syndrome (SARS), and it is highly contagious with significant mortality. In this study, we …

In silico predictions combined with in vitro, in vivo, and in situ observations collectively
suggest that mouse adaptation of the severe acute respiratory syndrome 2 virus requires an …